Aurora Analytica Project Starlite: Implementing Fit for Purpose Artificial Intelligence to Streamline and Optimize Clinical Research

Aurora Analytica aims to revolutionize clinical trial optimization through the Aurora Suite, an AI-driven platform that ingests data to streamline the clinical trial life cycle. By integrating analytics, data, and artificial intelligence, we provide a comprehensive solution that addresses the fragmented nature of current trial processes. This need is underscored by our Aurora Analytica Insights Survey, where over 60% of respondents reported lacking the necessary tools for effective trial management despite using multiple platforms.

Since our launch, we have raised 2.7 million NOK from government grants and investors within just 10 months, demonstrating strong traction in the industry. The Aurora Suite features 11 proprietary Decision Engines targeting critical areas of the clinical trial lifecycle, enhancing efficiency, reducing costs, and improving patient outcomes. Our technology has been validated through real-world applications, including significant results presented at the ESMO 2024 Congress, demonstrating accelerated site activation, faster patient enrollment, and substantial operational cost savings.

Led by Bhavish Lekh, who has over a decade of experience in clinical analytics, and Ola Gudmundsen, founder of LINK Medical with an impressive track record overseeing 550+ clinical trials, our team is uniquely positioned to drive innovation. Our strategic recruitment plan will bolster our capabilities in sales, app development, and subject matter expertise, ensuring we can scale effectively.

Aurora Analytica is committed to fostering an inclusive environment and transforming clinical trials for better societal and economic outcomes. With our comprehensive approach and demonstrated traction, we are poised to lead the future of clinical research.